Literature DB >> 21872634

Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB).

Anastasiya Yermakova1, Nicholas J Mantis.   

Abstract

The B subunit (RTB) of ricin toxin is a galactose-/N-acetyl galactosamine-specific lectin that promotes attachment and entry of ricin into host cells. RTB is also the archetype of the so-called R-type lectin family, whose members include haemagglutinins of botulinum neurotoxin (BoNT) progenitor toxins, as well as the binding subunits of cytolethal distending toxins. Although RTB is an appealing subunit vaccine candidate, as well as a potential target for immunotherapeutics, the degree to which RTB immunization elicits protective antibodies against ricin toxin remains unresolved. To address this issue, groups of mice were immunized with RTB and then challenged with 5×LD(50)s of ricin administered intraperitoneally. Despite high RTB-specific serum antibody titers, groups of RTB immunized mice were only partially immune to ricin challenge. Analysis of a collection of RTB-specific B cell hybridomas suggested that only a small fraction of antibodies against RTB have demonstrable neutralizing activity. Two RTB-specific neutralizing monoclonal IgG(1) antibodies, 24B11 and SylH3, when passively administered to mice, were sufficient to protect the animals against a 5×LD(50) dose of ricin. Both 24B11 and SylH3 blocked ricin attachment to terminal galactose residues and prevented toxin binding to the surfaces of bone marrow-derived macrophages (BMM), suggesting that they function by steric hindrance and recognize epitopes located on RTB's carbohydrate recognition sub-domains (1α or 2γ). These data raise the possibility of using specific RTB sub-domains, rather than RTB itself, as antigens to more efficiently elicit neutralizing antibodies and protective immunity against ricin.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872634      PMCID: PMC3191258          DOI: 10.1016/j.vaccine.2011.08.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  33 in total

Review 1.  The history of ricin, abrin and related toxins.

Authors:  Sjur Olsnes
Journal:  Toxicon       Date:  2004-09-15       Impact factor: 3.033

Review 2.  Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin.

Authors:  Nicholas J Mantis
Journal:  Adv Drug Deliv Rev       Date:  2005-06-17       Impact factor: 15.470

3.  RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

Authors:  Joan E Smallshaw; James A Richardson; Ellen S Vitetta
Journal:  Vaccine       Date:  2007-08-30       Impact factor: 3.641

4.  Crystallographic refinement of ricin to 2.5 A.

Authors:  E Rutenber; B J Katzin; S Ernst; E J Collins; D Mlsna; M P Ready; J D Robertus
Journal:  Proteins       Date:  1991

5.  Bone Marrow-Derived Macrophages (BMM): Isolation and Applications.

Authors:  Joachim Weischenfeldt; Bo Porse
Journal:  CSH Protoc       Date:  2008-12-01

6.  Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum.

Authors:  Kaoru Inoue; Mack Sobhany; Thomas R Transue; Keiji Oguma; Lars C Pedersen; Masahiko Negishi
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

7.  Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action.

Authors:  M P Ready; Y Kim; J D Robertus
Journal:  Proteins       Date:  1991

8.  Structure and evolution of ricin B chain.

Authors:  E Rutenber; M Ready; J D Robertus
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

9.  Immunological characteristics associated with the protective efficacy of antibodies to ricin.

Authors:  Massimo Maddaloni; Corrie Cooke; Royce Wilkinson; Audrey V Stout; Leta Eng; Seth H Pincus
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

10.  Mechanisms of assembly and cellular interactions for the bacterial genotoxin CDT.

Authors:  Dragana Nesic; C Erec Stebbins
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

View more
  39 in total

1.  Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies.

Authors:  Cristina Herrera; Jacqueline M Tremblay; Charles B Shoemaker; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

2.  Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.

Authors:  Yuwei Zhu; Jianxin Dai; Tiancheng Zhang; Xu Li; Pengfei Fang; Huajing Wang; Yongliang Jiang; Xiaojie Yu; Tian Xia; Liwen Niu; Yajun Guo; Maikun Teng
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

3.  Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

Authors:  David J Vance; Jacqueline M Tremblay; Nicholas J Mantis; Charles B Shoemaker
Journal:  J Biol Chem       Date:  2013-11-07       Impact factor: 5.157

4.  Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.

Authors:  Michael J Rudolph; David J Vance; Michael S Cassidy; Yinghui Rong; Nicholas J Mantis
Journal:  J Biol Chem       Date:  2016-11-30       Impact factor: 5.157

5.  Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice.

Authors:  Joanne M O'Hara; Robert N Brey; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

6.  Milk inhibits the biological activity of ricin.

Authors:  Reuven Rasooly; Xiaohua He; Mendel Friedman
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

7.  A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate.

Authors:  Junhong Wang; Shan Gao; Tao Zhang; Lin Kang; Wuchun Cao; Na Xu; Wensen Liu; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-02-07       Impact factor: 3.452

8.  Characterization and epitope mapping of the polyclonal antibody repertoire elicited by ricin holotoxin-based vaccination.

Authors:  Ofer Cohen; Adva Mechaly; Tamar Sabo; Ron Alcalay; Ronit Aloni-Grinstein; Nehama Seliger; Chanoch Kronman; Ohad Mazor
Journal:  Clin Vaccine Immunol       Date:  2014-09-10

9.  Chimeric plantibody passively protects mice against aerosolized ricin challenge.

Authors:  Erin K Sully; Kevin J Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do H Kim; Michael H Pauly; Jesus Velasco; Ernie Hiatt; Josh Morton; Kelsi Swope; Chad J Roy; Larry Zeitlin; Nicholas J Mantis
Journal:  Clin Vaccine Immunol       Date:  2014-02-26

Review 10.  Targeting ricin to the ribosome.

Authors:  Kerrie L May; Qing Yan; Nilgun E Tumer
Journal:  Toxicon       Date:  2013-02-20       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.